| Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials JY Chang, S Senan, MA Paul, RJ Mehran, AV Louie, P Balter, HJM Groen, ... The lancet oncology 16 (6), 630-637, 2015 | 1673 | 2015 |
| Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial L Voorwerk, M Slagter, HM Horlings, K Sikorska, KK van de Vijver, ... Nature medicine 25 (6), 920-928, 2019 | 820 | 2019 |
| Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients SN Ooft, F Weeber, KK Dijkstra, CM McLean, S Kaing, E van Werkhoven, ... Science translational medicine 11 (513), eaay2574, 2019 | 626 | 2019 |
| Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy S Leijen, SA Burgers, P Baas, D Pluim, M Tibben, E van Werkhoven, ... Investigational new drugs 33, 201-214, 2015 | 487 | 2015 |
| DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis LM Henricks, CATC Lunenburg, FM de Man, D Meulendijks, ... The Lancet Oncology 19 (11), 1459-1467, 2018 | 424 | 2018 |
| Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised … MS van Ramshorst, A van der Voort, ED van Werkhoven, IA Mandjes, ... The Lancet Oncology 19 (12), 1630-1640, 2018 | 361 | 2018 |
| Phase II Study of WEE1 Inhibitor AZD1775 Plus Carboplatin in Patients With TP53-Mutated Ovarian Cancer Refractory or Resistant to First-Line Therapy Within 3 … S Leijen, RMJM van Geel, GS Sonke, D de Jong, EH Rosenberg, ... Journal of Clinical Oncology 34 (36), 4354-4361, 2016 | 302 | 2016 |
| The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs DL van der Velden, LR Hoes, H Van Der Wijngaart, ... Nature 574 (7776), 127-131, 2019 | 240 | 2019 |
| Angiotensin II–receptor inhibition with candesartan to prevent trastuzumab-related cardiotoxic effects in patients with early breast cancer: a randomized clinical trial AH Boekhout, JA Gietema, BM Kerklaan, ED van Werkhoven, R Altena, ... JAMA oncology 2 (8), 1030-1037, 2016 | 227 | 2016 |
| Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival MC Van Harten, FJP Hoebers, KW Kross, ED Van Werkhoven, ... Oral oncology 51 (3), 272-278, 2015 | 215 | 2015 |
| Prognostic factors for local control in breast cancer after long-term follow-up in the EORTC boost vs no boost trial: a randomized clinical trial C Vrieling, E van Werkhoven, P Maingon, P Poortmans, C Weltens, ... JAMA oncology 3 (1), 42-48, 2017 | 166 | 2017 |
| Prognostic factors for occult inguinal lymph node involvement in penile carcinoma and assessment of the high-risk EAU subgroup: a two-institution analysis of 342 clinically … NM Graafland, W Lam, JAP Leijte, T Yap, MPW Gallee, C Corbishley, ... European urology 58 (5), 742-747, 2010 | 161 | 2010 |
| Long-term risk of dementia in persons with schizophrenia: a Danish population-based cohort study AR Ribe, TM Laursen, M Charles, W Katon, M Fenger-Grøn, D Davydow, ... JAMA psychiatry 72 (11), 1095-1101, 2015 | 158 | 2015 |
| The best of both worlds: a hybrid approach for optimal pre-and intraoperative identification of sentinel lymph nodes GH KleinJan, E Van Werkhoven, NS van Den Berg, MB Karakullukcu, ... European journal of nuclear medicine and molecular imaging 45, 1915-1925, 2018 | 157 | 2018 |
| Comparison of the value of nursing work environments in hospitals across different levels of patient risk JH Silber, PR Rosenbaum, MD McHugh, JM Ludwig, HL Smith, ... JAMA surgery 151 (6), 527-536, 2016 | 156 | 2016 |
| Comparison of the value of nursing work environments in hospitals across different levels of patient risk JH Silber, PR Rosenbaum, MD McHugh, JM Ludwig, HL Smith, ... JAMA surgery 151 (6), 527-536, 2016 | 156 | 2016 |
| Penile sparing surgery for penile cancer—does it affect survival? RS Djajadiningrat, E van Werkhoven, W Meinhardt, BWG van Rhijn, ... The Journal of urology 192 (1), 120-126, 2014 | 153 | 2014 |
| Contemporary management of regional nodes in penile cancer—improvement of survival? RS Djajadiningrat, NM Graafland, E van Werkhoven, W Meinhardt, A Bex, ... The Journal of urology 191 (1), 68-73, 2014 | 140 | 2014 |
| Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicity D Meulendijks, LM Henricks, BAW Jacobs, A Aliev, MJ Deenen, ... British journal of cancer 116 (11), 1415-1424, 2017 | 138 | 2017 |
| Human papillomavirus prevalence in invasive penile cancer and association with clinical outcome RS Djajadiningrat, ES Jordanova, BK Kroon, E van Werkhoven, J de Jong, ... The Journal of urology 193 (2), 526-531, 2015 | 134 | 2015 |
Sabine LinnProfessor of Translational Oncology - Utrecht University; Group leader NKI AmsterdamVerified email at nki.nl
